Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Ecthyma

imatinib mesylate has been researched along with Ecthyma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekine, T; Suzuki, K2

Other Studies

2 other study(ies) available for imatinib mesylate and Ecthyma

ArticleYear
[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2014, Volume: 88, Issue:3 Suppl 9-

    Topics: Aged; Antineoplastic Agents; Benzamides; Ecthyma; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Orbit; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines

2014
[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2009, Volume: 83, Issue:6

    Topics: Aged; Antineoplastic Agents; Benzamides; Ecthyma; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines

2009